Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

BIO Balance Sheet

Assets, liabilities, and equity analysis

BIO Quarterly Balance Sheet (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
Total Current Assets
2.942B2.942B2.906B2.842B2.811B3.037B3.030B3.056B3.056B
507.200M507.200M531.800M397.800M369.300M521.400M488.100M410.377M406.913M
Short-Term Investments
1.058B1.058B1.011B1.023B1.004B1.139B1.176B1.212B1.209B
Cash & Short-Term Investments
1.565B1.565B1.543B1.421B1.374B1.660B1.665B1.622B1.616B
439.500M439.500M472.500M474.200M469.900M424.700M452.500M461.940M445.506M
0.000.00740.700M783.200M798.800M790.100M760.000M804.276M803.693M
Total Assets
9.790B9.790B10.576B9.696B10.214B9.527B9.364B10.603B9.688B
0.000.00709.900M720.500M740.100M681.700M688.600M719.170M715.240M
577.100M577.100M579.800M578.700M581.600M414.600M410.500M415.100M412.100M
Intangible Assets
166.800M166.800M174.300M388.400M396.900M296.100M293.600M307.300M307.100M
Long-Term Investments
5.312B5.312B6.104B5.058B5.577B4.994B4.839B6.003B5.100B
Total Current Liabilities
917.000M917.000M517.000M522.300M548.900M506.600M467.800M497.943M486.961M
133.100M133.100M129.000M128.800M139.300M137.900M122.300M122.185M126.693M
436.700M436.700M37.900M38.100M1.300M1.200M1.200M1.262M0.00
Total Liabilities
2.939B2.939B3.123B2.960B3.085B2.848B2.795B3.116B2.910B
794.300M794.300M1.339B1.193B1.201B1.201B1.200B1.200B1.190B
1.378B1.378B1.531B1.395B1.407B1.369B1.375B1.388B1.393B
Net Debt (Cash)
871.000M871.000M999.200M997.500M1.037B848.100M886.600M977.738M985.758M
Total Shareholders' Equity
6.851B6.851B7.454B6.737B7.129B6.679B6.569B7.488B6.779B
Common Stock
0.000.000.000.000.000.000.003K3K
7.649B7.649B8.176B7.456B7.798B7.480B7.416B8.132B7.479B
3.213.215.625.445.125.996.486.146.28
0.200.200.210.210.200.210.210.190.21

BIO Annual Balance Sheet (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Current Assets
2.906B3.030B3.048B3.158B1.990B2.140B2.180B2.023B
531.800M488.100M403.800M434.215M470.783M662.205M660.672M431.526M
Short-Term Investments
1.011B1.176B1.203B1.356B399.135M328.913M453.973M413.270M
Cash & Short-Term Investments
1.543B1.665B1.607B1.791B869.918M991.118M1.115B844.796M
472.500M452.500M489.000M494.645M423.537M419.424M392.672M392.443M
740.700M760.000M780.500M719.316M572.239M622.253M554.007M583.815M
Total Assets
10.576B9.364B12.299B13.502B17.799B12.973B8.009B5.611B
709.900M688.600M723.700M679.552M716.437M693.507M701.207M508.690M
579.800M410.500M413.600M406.500M347.300M291.900M264.100M219.800M
Intangible Assets
174.300M293.600M320.500M332.100M253.900M199.500M145.500M133.100M
Long-Term Investments
6.104B4.839B7.698B8.831B14.387B9.561B4.638B2.656B
Total Current Liabilities
517.000M467.800M522.800M568.708M680.938M631.536M905.495M450.795M
129.000M122.300M144.600M135.041M141.941M139.451M107.014M122.450M
37.900M1.200M500K465K489K1.300M425.700M493K
Total Liabilities
3.123B2.795B3.558B3.886B4.114B3.093B2.254B1.591B
1.339B1.200B1.199B1.198B10.514M1.300M2.400M438.937M
1.531B1.375B1.405B1.388B223.376M225.735M651.183M439.430M
Net Debt (Cash)
999.200M886.600M1.002B953.883M-247.407M-436.470M-9.489M7.904M
Total Shareholders' Equity
7.454B6.569B8.741B9.615B13.685B9.880B5.755B4.020B
Common Stock
0.000.000.003K3K3K3K3K
8.176B7.416B9.261B9.898B13.525B9.268B5.471B3.722B
5.626.485.835.552.923.392.414.49
0.210.210.160.140.020.020.110.11

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz